GEN
- Alzheimer’s Disease and Aging Linked to Changes in the HypothalamusGEN ·
Researchers combined measurements from brain images and single cell transcriptome maps to build a resource, HypoAD, as an atlas of the human hypothalamus in aging and AD, which they have made available to the research community.
- CRISPR Screening Reveals How Genetic Variants Drive Neurodegenerative RiskGEN ·
Researchers studying human induced pluripotent stem cell-derived microglia-like cells showed how genetic variants can impact cell behavior and used CRISPR gene editing to show how one gene’s effect depends on its cellular context.
- Targeting Folate Receptor Reverses Colorectal Cancer’s Resistance to Immunotherapy in MiceGEN ·
Targeting FOLR1 with an approved antibody-drug conjugate restored anti-tumor immunity and enhanced anti-PD-1 effectiveness in colorectal cancer, overcoming immune evasion in mouse models.
- London Calling: Flagship Expands in U.K. to Build AI-Native Platform CompaniesGEN ·
Flagship expects to recruit and train an initial team of approximately 50 U.K.-based scientist-entrepreneurs and operators for the new Origination Lab, U.K., which will build on three years of experience partnering and conducting R&D across the kingdom.
- The Advent of Automated, Gene-Engineered TIL ManufacturingGEN ·
Automating engineered TIL manufacturing in a way that maintains their tumor-fighting capabilities may move this emerging therapeutic class into a commercially reproducible, economically viable therapeutic option.
- Tuning Extracellular Vesicle Production and Analytics for ComplianceGEN ·
The complexity of extracellular vesicle products developed from umbilical cord blood can potentially be reduced through production processes and simplified quality control strategies, helping to boost this new product class.
- One Record, From Factory Floor to PatientGEN ·
ParkourSC acquired manufacturing-AI company Quartic to track a drug’s quality across its whole lifecycle.
- Growing Apart: Culture-Based Sterility Test AlternativesGEN ·
Growth-based sterility testing works for traditional biopharma but is too slow for the cell therapy sector. A new parallel testing pathway and rapid, molecular assay-based testing are a better option.
- Alcohol Suppresses Some T Cells, Boosts Others, Blunting Anti-PD-1 Response in MiceGEN ·
In mice, alcohol cut the efficacy of anti-PD-1 immunotherapy by roughly 50%, suppressing tumor-infiltrating and memory T cells while boosting TIGIT-carrying ones. Blocking TIGIT restored the response.
- Beyond Amyloid and Tau: Alzheimer’s Drug Developer Sees Early Clinical Success for Immunotherapy-Based ApproachGEN ·
ImmunoBrain's approach contrasts with decades of conventional thinking among researchers, which held that Alzheimer’s was a disease of toxic proteins—an outgrowth of thinking that immune activity in the brain was in itself a sign of pathology.
- Genetic Barcoding Reveals How Pre-Bone Marrow Transplant Conditioning Impacts Immune System RegenerationGEN ·
Researchers used genetic barcoding to track human blood-forming stem and progenitor cells transplanted into mice, revealing how the different cell types regenerate the blood and immune system, and how different forms of pretransplant conditioning affected blood and immune cell recovery.
- Mapping the Hidden Viral Communities of the Human Gut MicrobiomeGEN ·
Researchers identified over 116,000 gut viral groups, revealing previously unknown relationships between viruses, bacteria, and metabolism, with findings offering new insights into gut health and irritable bowel syndrome (IBS).
- Enhancer-Targeted CRISPR Turns Up Healthy Gene Copy in Autism Organoid ModelGEN ·
In lab-grown human neurons and organoids carrying CHD8 or SCN2A mutations, researchers reduced organoid overgrowth and moved neuronal electrical activity closer to wild-type levels.
- Toward Connected Laboratory EcosystemsGEN ·
In this GEN podcast, the third in a series, LabVantage’s Denise Bell discusses how laboratories can reduce operational fragmentation and build connected, scalable operations.
- Gut Microbome and Bile Acid Modification Linked with LongevityGEN ·
Researchers studying how gut microbes modify bile acids have identified changes in the metabolic activity of the gut microbiome associated with exceptional longevity in humans, and found that amplifying the same activity with engineered bacteria improved metabolic health in aged mice.
- Single-Cell Method Reveals On- and Off-Target Effects of Cas9 Edits on Gene ExpressionGEN ·
A new method called Superb-seq pairs Cas9 editing with single-cell RNA sequencing to show which edits, including off-target ones, occur in each cell and how they alter gene expression, offering a clearer view of genome editing’s potential consequences.
- StockWatch: Amid Nvidia Turmoil, What Happens to Its Life Sciences Collaborations?GEN ·
While Nvidia doesn’t develop new therapies, instruments, or reagents, its AI technology powers numerous collaborations with biopharma and lab tools giants stretching back at least five years.
- DCIS Cell Atlas Reveals Clues to Invasive Breast Cancer ProgressionGEN ·
Researchers created a detailed map of the tumor microenvironment surrounding estrogen receptor-positive ductal carcinoma in situ , which may help better predict progression to invasive breast cancer and inform on future therapeutic strategies.
- How Vancomycin-Resistant Enterococcus Evolved in a Danish HospitalGEN ·
A genomic study reveals how genetic mutations, recombination, and resistance-carrying plasmids shaped the evolution, diversification, and decline of vancomycin-resistant Enterococcus faecium in Danish hospitals between 2012 and 2020.
- Downstream Processing: Purifying Complex Antibody Therapeutics When Target Molecules MisbehaveGEN ·
In this GEN webinar, downstream process development and scale up manufacturing specialists will discuss practical strategies for building robust purification processes when the target molecule misbehaves.
- Reference Genomes of Malaria-Causing Plasmodium Parasites CompletedGEN ·
Using DNA sequenced from patient blood samples, researchers assembled complete reference genomes of neglected malaria parasites, uncovering genetic regions potentially involved in immune evasion and providing new tools for disease surveillance.
- High Frequency of Drug-Impacting Gene Variants Found in All of Us CohortGEN ·
A study finds that everyone in a diverse, nearly 100,000-person sample carried at least one genetic variant that affects how their body processes medications, and a quarter of those people had been prescribed a medication that is known to be impacted by the variant they carried.
- Neuroprotective Protein Atlas Positions the Blood-Brain Barrier as a Selective CheckpointGEN ·
The blood-brain barrier keeps most proteins in the bloodstream out of the brain, but not all.
- How Breast Cancer Chemotherapy May Impact Biological Aging and Loss of Healthy Life YearsGEN ·
Chemotherapy helps many women survive breast cancer, but the results of new research suggest that chemotherapy may also accelerate biological aging beyond chronological age and increase the risk of earlier death from other causes.
- From Farm Waste to Medical NanoparticlesGEN ·
Fruit peels, rice husks, and other crop leftovers can yield biomedical nanoparticles, but variable feedstocks, scale-up hurdles, and thin safety data still stand between lab promise and reliable commercial bioprocessing.
- Hybrid Model Captures Lactate Run-Away and Back-MetabolismGEN ·
A hybrid model provides hard-to-achieve insights into lactate performance during bioprocessing, creating conditions for more accurate predictions to better manage key batch parameters and variability.
- Extracellular Vesicle Product Developer Creates Potency AssayGEN ·
A company developing extracellular vesicle-based products has developed a potency assay for quality control. They hope to adapt it for future products and scale it to commercial manufacturing.
- Automation a Path to Lower Cell Therapy CostsGEN ·
Australian developer Currus Bio predicts that automating the production of its candidate cancer cell therapy, CUR-001, using the Cocoon platform will reduce costs and enhance its ability to scale production as the product moves through trials.
- Argenx Expands Immunology Capabilities with Up-to-$1.15B UNP AcquisitionGEN ·
The deal is designed to marry UNP’s macrocyclic peptide discovery platform with Argenx’s immunology innovation capabilities to broaden the buyer’s ability to develop oral or long-acting treatments for serious immune-mediated diseases.
- Illumina Offers Early Access to Duplex Sequencing for MRD, Tumor Evolution ResearchGEN ·
Illumina has announced an early access program to a duplex sequencing workflow that reads both DNA strands to detect trace ctDNA in molecular residual disease and tumor evolution studies.
- How Cancer-Associated Gene Triggers Cell Division Without Unpacking the GenomeGEN ·
A study showed how E2F1 can trigger cell division without having to unpack the cell’s genetic material.
- Childhood Cancers May Not Always Need Extra Mutations to Spread, Study SuggestsGEN ·
Childhood cancers may not always need extra mutations to spread, a new review study indicates.
- New AI Models Are Turbo-Charging Protein DesignGEN ·
Computer-designed protein therapeutics move from proof-of-concept to wet-lab validation and even clinical trials as the field heats up.
- Therapeutic Immune ManipulationGEN ·
Next-generation immunotherapy exploits diverse immune populations to address the challenges that CAR T-cell therapy faces.
- Formulation Development RoundupGEN ·
What leaders suggest are the key considerations for developing robust formulations.
- StockWatch: Nurix Nosedives as Sanofi Halts Phase I Immunology CandidateGEN ·
Sanofi halted development of an oral STAT6 degrader that had been under study in a Phase I first-in-human trial in Europe.
- The Aging Proteome: Clocks, Cohorts, and Clinical TrialsGEN ·
In this GEN webinar, two experts will show how ultra-sensitive, multiplexed proteomics can measure both the pace of aging and the effects of interventions designed to change it.
- Novartis Confirms Nine Cases of Tumors in Children Treated with Gene Therapy ZolgensmaGEN ·
"Two cases to date have shown evidence of vector integration into the DNA of the patients. In both cases, the patients underwent treatment and continue to be monitored,” Novartis said in a statement.
- ER-Negative Breast Cancer Risk Linked with Blood Levels of Two PFAS Forever ChemicalsGEN ·
The results of a study found that women with higher blood levels of two common PFAS were more likely to develop estrogen receptor-negative breast cancer, saying their results have important public health implications.
- Why Glycosylation Control Is No Longer a Secondary Concern in the Development of Complex BiologicsGEN ·
A priority shift is redefining expectations for contract development and manufacturing organizations (CDMOs).
- Where DNA Copying Fails Can Decide How Cancer Cells Respond to PARP InhibitorsGEN ·
NYU Grossman School of Medicine researchers found that DNA-copying problems at a small set of chromosome sites can determine how cancer cells respond to PARP inhibitors, pointing to possible biomarkers of drug sensitivity.
- Boehringer Ingelheim Inks Up-to-$7.4B+ Cancer Drug Collaboration with Sino BiopharmaceuticalGEN ·
The latest collaboration will encompass six biologic preclinical programs. Five programs focus on treatments originating with a wholly owned SBP Group subsidiary, LaNova Medicines.
- Bird Flu Vaccine Developed Using AI Outperforms Current Stockpiled Vaccines in Preclinical TestsGEN ·
Researchers used an AI-guided engineering approach to create a broadly protective bird flu vaccine that is designed to remain effective across a wide range of existing and future H5Nx variants.
- Orphan Therapeutics Accelerator In-Licenses Its First Gene Therapy, Eyes Pipeline ExpansionGEN ·
The nonprofit biotech evaluates potential therapies based on unmet medical need, clinical evidence of safety and efficacy, and the compatibility of institutional partners.
- Tissue Engineering Takes ShapeGEN ·
Personalized grafts, bioinks, and off-the-shelf tissues are advancing regenerative medicine toward broader clinical use.
- Beyond Conventional CRISPRGEN ·
Genome editing is not designed to replace neurons or retinal cells that have already been lost.
- Oral Sleep Apnea Therapy Poised to Expand Treatment OptionsGEN ·
An oral obstructive sleep apnea therapy targeting multiple pathways is poised to improve patient compliance and, possibly, outcomes.
- Beyond the PayloadGEN ·
In this Point of View Anthony Blaszczyk, PhD, principal scientist at USP provides insights on how delivery technologies will shape the future of cell and gene therapy.
- Revealing the Chemistry Around Us Through Mass SpectrometryGEN ·
Mass spectrometry-based exposomics could be a powerful approach to measuring and understanding environmental impact on health.
- What Biotech Licensing Really BuysGEN ·
In this Point of View Sun Chau Siu, PhD, and Kaisong Zhou, PhD, give insights on the hidden challenges of transferring intellectual property.